Cigna Investments’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-7,176
Closed -$524K 692
2019
Q2
$524K Buy
7,176
+3,591
+100% +$213K 0.06% 382
2019
Q1
$251K Sell
3,585
-42
-1% -$3.11K 0.03% 583
2018
Q4
$234K Sell
3,627
-4,916
-58% -$345K 0.02% 617
2018
Q3
$612K Buy
+8,543
New +$500K 0.05% 306

Other funds holding GHDX

Cigna Investments's GHDX Position: Q3 2019 in Review

Cigna Investments sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 7,176 shares — an estimated $524K sold.

Cigna Investments first reported a position in GHDX in Q3 2018 and held it in 4 quarters. The position peaked at $612K in Q3 2018. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Cigna Investments reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Cigna Investments sold 7,176 Genomic Health, Inc. shares in Q3 2019, an estimated $524K.
  • Cigna Investments first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 4 quarters.
  • Cigna Investments's Genomic Health, Inc. position peaked at $612K in Q3 2018.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Cigna Investments's 13F filing for Q3 2019, filed 7 Nov 2019.